781-237-3800
Donate
Contact
Search

Inside the Alzheimer’s Lab: Rudy Tanzi, Ph.D.

Posted March 20, 2014

Dr. Rudy Tanzi of Harvard Medical School/Mass General Hospital talks to David Shenk about his research into CD33 inhibitors, which show promise in curtailing the damaging brain inflammation that occurs in Alzheimer’s disease.

Alzheimer's Treatment Videos

Inside the Alzheimer’s Lab: Interviews With Our Researchers

Back to News and Events

Inside the Alzheimer’s Lab: David Holtzman, M.D.

Protecting Synapses in Adults: An Early Intervention for Alzheimer’s?

Amyloid Screening and its Role in Alzheimer’s Diagnosis

Alzheimer’s and Antidepressants: Dr. Rudy Tanzi Comments

Alzheimer’s and Antidepressants: Rudy Tanzi, Ph.D. on CBS

Our Mission

Promising Update on Efficacy and Safety of “Molecular Tweezers”

Related Content: